Podcast: Play in new window | Download
Subscribe: Google Podcasts | RSS
We talk with Dr. Andrew Horwitz Vice President, R&D at Sestina Bio LLC about producing cannabinoids outside the cannabis plant. Previously, Andrew managed the Cannabinoid R&D program at Demetrix, where he helped develop the process for using genetically modified yeast cells to produce cannabinoids. We discuss:
- The advantages of using yeast cells to produce cannabinoids instead of cannabis and hemp plants
- How adjusting the precursor molecules that are fed to the yeast cells can produce rare and novel cannabinoids
- How cannabis medicine researchers can use this technology to better understand the entourage effect
- Why understanding the way the cannabis plant produces cannabinoids was essential to developing this technology
- How this technology is received by the cannabis community
Thanks to our Sponsor: Demetrix
Demetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces safe, legal, and effective health and wellness products backed by science, including rare, high-purity cannabinoids for pharmaceutical and consumer applications.
To learn more, please visit www.demetrixbio.com, and be sure to check out their blog, www.demetrixbio.com/insights.
Additional Resources